Treatment-resistant self-mutilation, tics, and obsessive-compulsive disorder in neuroacanthocytosis: a mouth guard as a therapeutic approach.
Fontenelle
Leonardo F
LF
Leite
Marco Antônio Araújo
MA
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001284:Atrophy / Q000150:complications / Q000473:pathology; D002421:Caudate Nucleus / Q000473:pathology; D002998:Clonazepam / Q000627:therapeutic use; D003024:Clozapine / Q000627:therapeutic use; D003987:Dibenzothiazepines / Q000627:therapeutic use; D004576:Electromyography; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009064:Mouth Protectors; D054546:Neuroacanthocytosis / Q000150:complications*; D009771:Obsessive-Compulsive Disorder / Q000150:complications* / Q000188:drug therapy*; D000069348:Quetiapine Fumarate; D016728:Self-Injurious Behavior / Q000150:complications* / Q000517:prevention & control*
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D005473:Fluoxetine; D000069348:Quetiapine Fumarate; D002998:Clonazepam; D003024:Clozapine